T.C. Kok

Evaluation of antiandrogen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial.

C Grimaldi, Harry Bleiberg, Francesca Gay et al. · Journal of Clinical Oncology · 1998 · 135 citations

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

M. Polée, Wim C.J. Hop, T.C. Kok et al. · British Journal of Cancer · 2003 · 97 citations · Full text

Assessment of Response of Esophageal Carcinoma to Induction Chemotherapy

M. L. Hordijk, T.C. Kok, J. H. P. Wilson et al. · Endoscopy · 1993 · 64 citations

Esophageal Cancer, Endoscopic Imaging, Medical Imaging +12

Phase II study of miltefosine (Hexadecylphosphocholine) in advanced soft tissue sarcomas of the adult— An EORTC Soft Tissue and Bone Sarcoma Group study

Jaap Verweij, Krzysztof Krzemieniecki, T.C. Kok et al. · European Journal of Cancer · 1993 · 45 citations

Radiation Oncology, Phase Ii Study, Pathology +1

No evidence of known types of human papillomavirus in squamous cell cancer of the oesophagus in a low-risk area

T.C. Kok, Kees Nooter, Steven P. Tjong‐A‐Hung et al. · European Journal of Cancer · 1997 · 40 citations · Full text

Squamous Cell Cancer, Low-risk Area, Esophagus +9